Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 5/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | GMNN | O75496 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | CCR5 | P51681 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.40 |
| ▸ | MME | P08473 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3398553 | 1.00 | SRC (0.53) | SRCLMNAALDH1A1POLBKMT2A | |
| SCHEMBL249115 | 1.00 | SRC (0.53) | SRCLMNAALDH1A1POLBKMT2A | |
| SCHEMBL3141262 | 0.84 | SRC (0.50) | SRCLMNAALDH1A1POLBKMT2A | |
| SCHEMBL27732531 | 0.83 | SRC (0.53) | SRCLMNAALDH1A1CYP2D6CYP2C19 | |
| SCHEMBL1663424 | 0.83 | SRC (0.53) | SRCLMNAALDH1A1CYP2D6CYP2C19 | |
| SCHEMBL776396 | 0.83 | LMNA (0.46) | SRCLMNAALDH1A1POLBKMT2A | |
| SCHEMBL14955046 | 0.83 | SRC (0.57) | SRCLMNAALDH1A1POLBKMT2A | |
| SCHEMBL14955287 | 0.83 | SRC (0.57) | SRCLMNAALDH1A1POLBKMT2A | |
| SCHEMBL355147 | 0.82 | SRC (0.44) | SRCLMNAALDH1A1POLBKMT2A | |
| SCHEMBL5357827 | 0.82 | SRC (0.34) | SRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101910188-B | Process for producing optically active amines | SUMITOMO CHEMICAL CO | 2013-05-08 | — | — | CN | disclosed |
| EP-2246356-B1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE AMINES | SUMITOMO CHEMICAL CO (JP) | 2013-04-03 | — | — | EP | disclosed |
| US-20110054171-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE AMINES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-03-03 | — | — | US | disclosed |
| CN-101910188-A | Process for producing optically active amines | SUMITOMO CHEMICAL CO | 2010-12-08 | — | — | CN | disclosed |
| EP-2246356-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE AMINES | Sumitomo Chemical Company, Limited (JP) | 2010-11-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110054171-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE AMINES | TYR, ARSA, ODC1 | SRC 3642/4885LMNA 3374/4885ALDH1A1 98/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.